Navigation Links
Bill & Melinda Gates Foundation Rewards 76 New Ideas to Fight Infectious Disease
Date:10/20/2009

Scientists from Africa and Europe selected for their unconventional projects to accelerate the eradication of malaria, HIV and AIDS, tuberculosis and other infectious diseases

ARUSHA, Tanzania, Oct. 20 /PRNewswire-USNewswire/ -- The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.

"Some of the biggest stumbling blocks in global health are now being overcome with promising new vaccines and treatments," said Dr. Tachi Yamada, president of the Gates Foundation's Global Health Program. "Grand Challenges Explorations will continue to fill the pipeline with possibilities and hopefully produce a breakthrough idea that could save untold numbers of lives."

This marks the third round of the foundation's Grand Challenges Explorations initiative to expand the pipeline of ideas for improving global health. To date, 262 researchers representing 30 countries have been awarded Grand Challenges Explorations grants.

In total, 76 grantees from round 3 were selected from almost 3,000 proposals. All levels of scientists are represented - from young post-graduate investigators to veteran researchers - as are a wide range of disciplines, such as chemistry, bioengineering, electronics, mechanical engineering, infectious disease, and epidemiology. This year's European and African grantees are based at universities, research institutes, nonprofit organizations, and private companies in Kenya, South Africa, Uganda, Zambia, Finland, Italy, the Netherlands, Sweden and the UK. Examples of newly-funded projects include:

  • Innovative ways to diagnose infectious diseases:
    • Jackie Obey from the University of Eastern Africa in Kenya will test the efficacy of a test tube kit to indicate the presence of a protein released by the malaria parasite New strategies to fight malaria and mosquitoes
  • New strategies to fight malaria and mosquitoes:
    • Annette Habluetzel of the University of Camerino in Italy will create a micropellet food which, when activated by the sun, could generate toxins that kill mosquito larvae
    • Peter Lubega Yiga of AdhocWorks Foundation in South Africa will test the efficacy of a fermentation-based household mosquito repellent
  • More effective vaccines:
    • Margaret Njoroge of Med Biotech Laboratories in Uganda will develop an intranasal vaccine for mothers, designed to induce antibodies against malaria in breast milk and confer immunity on their babies

Notes to Editor

About Grand Challenges Explorations

Grand Challenges Explorations is a five-year, $100 million initiative to promote innovation in global health. It is part of the Grand Challenges in Global Health initiative, which is supported by the Gates Foundation to achieve major breakthroughs in global health.

Applications for the next round of Grand Challenges Explorations are being accepted through November 2, 2009. Grant application instructions, including the list of topics for which proposals are currently being accepted, are available at http://www.grandchallenges.org/explorations.

Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people--especially those with the fewest resources--have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Jeff Raikes and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett. Learn more at www.gatesfoundation.org.

For high-resolution still photography and information about the foundation's work, please visit: www.gatesfoundation.org/press-room/Pages/news-market.aspx.

Round 3 Winners in Africa

  • Jackie Obey, University of Eastern Africa, Baraton, Kenya: 'Malaria diagnosis using iron and plasma'
  • Margaret Njoroge-Mendi, Med Biotech Laboratories, Uganda: 'Maternal Immunization to protect infants against malaria'
  • Dr Sungano Mharakurwa, Malaria Institute at Macha, Zambia: 'Pre-Season Elimination of Malaria Carrier Infections'
  • Peter Lubega Yiga, AdhocWorks CC, South Africa: 'A fermentation-based mosquito-repelling device'

Round 3 Winners in Europe

  • Claudia Pastori, Fondazione S. Raffaele del Monte Tabor, Italy: 'Induction of HIV protective mucosal antibodies'
  • Dr Edward Dolk, Utrecht University, The Netherlands: 'Increased mucosal immunity combined with excretion of HIV'
  • Dr Michael Lebens, University of Gothenburg, Sweden: 'A novel effective vaccine against cholera'
  • Dr Shahid Khan, University of Leiden Medical Centre, The Netherlands: 'Preventing malaria in both host and vector'
  • Dr Annette Habluetzel, University of Camerino, Italy: 'Photocidal porphyrin micro-pellets for larvae control'
  • Dr Matthew Fuchter, Imperial College, London, UK: 'Targeting of the P. falciparum Immune Evasion Mechanism to Treat Malaria'
  • Lena Hulden, University of Helsinki, Finland: 'Seasonal vivax malaria eradication'
  • Dr Jeremy Webb, University of Southampton, UK: 'New whole-species pneumococcal vaccines'
  • Dr Federica Marelli-Berg, Imperial College, London, UK: 'Programming T cell homing to induce gut-selective immunity'
  • Dr Roly Gosling, London School of Hygiene & Tropical Medicine, UK: 'Targeting hotspots in rural poorly-resourced settings'

SOURCE Bill & Melinda Gates Foundation


'/>"/>
SOURCE Bill & Melinda Gates Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: